Background: The relationship between TB/HIV co-infection and common mental disorders (CMD) is not well investigated. A follow up study was conducted to assess the change in CMD over a 6-months period and its predictors among TB/HIV co-infected and HIV patients without TB in Ethiopia.

Methods: A longitudinal study was conducted in 2009. A total of 465 HIV/AIDS patients without TB and 124 TB/HIV co-infected patients from four antiretroviral treatment (ART) centers in Ethiopia were recruited to assess CMD and quality of life (QoL). CMD and QoL were assessed at baseline and at six month using the Kessler-10 scale and the short Amharic version of the World Health Organization Quality of Life Instrument for HIV clients (WHOQOL HIV-Bref) respectively. Multivariate analysis was conducted using generalized estimating equations (GEE) using STATA to assess change in CMD and its predictors.

Results: At the 6 month, 540 (97 TB/HIV co-infected and 455 HIV/AIDS patients without TB) patients completed the follow up and 8.6% (21% among TB/HIV co-infected and 2.2% among HIV patients without TB) lost to follow-up.At baseline, 54.4% of TB/HIV co-infected patients had mild to severe mental disorder compared to 41.2% among HIV patients without TB. At the six month follow up, 18.1% of TB/HIV co-infected patients had mild to severe mental disorder compared to 21.8% among HIV patients without TB. The decline of the prevalence of any form of metal disorder was 36.3% among TB/HIV co-infected patients compared to 19.4% among HIV patients without TB (P<0.001).QoL was strongly associated with CMD in TB/HIV co-infected patients and HIV patients without TB (β = -0.04, P<0.001) after controlling the effect of several confounding variables such as sex, income, WHO disease stage, duration on ART, CD4 lymphocyte count, adherence to ART and social support.

Conclusion: The prevalence of CMD has significantly reduced particularly among TB/HIV co-infected patients over a 6 months period. Poor QoL is the major independent predictors of CMD. We recommend integration of mental health services in TB/HIV programs. Training of health care providers at TB/HIV clinics could help to screen and treat CMD among TB/HIV co-infected patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702441PMC
http://dx.doi.org/10.1186/1471-244X-13-174DOI Listing

Publication Analysis

Top Keywords

tb/hiv co-infected
32
hiv patients
24
co-infected patients
16
patients
13
tb/hiv
9
common mental
8
mental disorders
8
co-infected
8
co-infected hiv
8
patients antiretroviral
8

Similar Publications

Background: HIV-TB co-infection poses a significant public health threat, notably in sub-Saharan Africa including Ethiopia. Despite this public health problem, studies in Ethiopia regarding the mortality of HIV-TB co-infection patients have been inconsistent, and the overall estimate of mortality was not determined. Accordingly, this meta-analysis aims to assess the magnitude of mortality and predictors among HIV-TB co-infected patients in Ethiopia.

View Article and Find Full Text PDF

Deciphering long-term immune effects of HIV-1/SARS-CoV-2 co-infection: a longitudinal study.

Med Microbiol Immunol

December 2024

Immunology Section, Molecular Immuno-Biology Laboratory, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.

Introduction: While the general immune response to Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is well-understood, the long-term effects of Human Immunodeficiency Virus-1/Severe Acute Respiratory Syndrome-Coronavirus-2 (HIV-1/SARS-CoV-2) co-infection on the immune system remain unclear. This study investigates the immune response in people with HIV-1 (PWH) co-infected with SARS-CoV-2 to understand its long-term health consequences.

Methods: A retrospective longitudinal study of PWH with suppressed viral load and SARS-CoV-2 infection was conducted.

View Article and Find Full Text PDF
Article Synopsis
  • * Involving 200 newly diagnosed HIV-1 patients, the research revealed significant correlations, such as lower hemoglobin levels linked to higher CD4+ counts and lower PVL, while abnormalities in various blood parameters were more pronounced in those co-infected with HIV-TB.
  • * The findings suggest that specific hematological and biochemical indicators, including hemoglobin and inflammatory markers, could serve as early warning signs for TB in HIV-infected individuals, enhancing patient management
View Article and Find Full Text PDF

Background:  South Africa has seen strides in reducing HIV and tuberculosis (TB); however, adherence counselling for people living with HIV (PLHIV) coinfected with TB remains a challenge, particularly in specific sub-districts like Cape Town. Understanding the attributes of existing training programmes is crucial.

Objectives:  This study explored attributes of training programme development for nurses and other health professionals to enhance adherence counselling for PLHIV coinfected with TB in Cape Town.

View Article and Find Full Text PDF
Article Synopsis
  • Tuberculosis (TB) is facing a significant challenge due to drug resistance, with Cameroon reporting a 1.4% prevalence of drug-resistant TB among new cases and 8.3% among those being retreated in 2022.
  • A study analyzed data from 2013 to 2022 in Cameroon, examining the trends, risk factors, and treatment outcomes related to drug-resistant TB, finding a total of 567 reported cases.
  • The study reported a high database quality (93.7%) and highlighted concerning treatment outcomes, including an 11.9% refusal rate and a 14.8% case fatality rate, with male gender and HIV-positive status identified as significant risk factors for poor treatment outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!